CM 29-712

Also Known As:

CM 29712; 6-methyl-8 alpha-1-cyanomethylergoline

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Parkinson Disease (Parkinson's Disease) 01/01/1983 - "Clinical responses to bromocriptine and three new ergoline derivatives, CM 29-712, CQ 32-084, and CU 32-085, in the treatment of Parkinson's disease were studied in new, non-levodopa-treated parkinsonian patients. "